Search

everythinglearnresearchcommunity

for

Search:↓

Spironolactone may help reduce COVID-19 severity in men by blocking harmful effects of certain hormones.

Natural products can help heal wounds by affecting key biological pathways.

Noggin promotes skin tumors by activating certain cell signaling pathways.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

Mutant keratins cause inflammation in Epidermolysis Bullosa Simplex, suggesting targeting them could help treat the disorder.

Understanding EGFR roles could lead to new hair loss treatments.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

SOCS1 and SOCS3 help control skin inflammation and are important for developing treatments for skin diseases.

New treatments like JAK inhibitors show promise for reversing alopecia areata.

Ustekinumab successfully treated a man's resistant skin condition when other treatments failed.

Understanding tissue self-organization can improve treatments for diseases and advance regenerative medicine.

EGF receptor is crucial for skin health and its inhibitors can cause skin rashes.

Blocking EGFR can cause skin inflammation by disrupting IL-1 signaling.

Astaxanthin may reduce inflammation in women with PCOS, but doesn't significantly improve symptoms.

Some drugs may help treat both COVID-19 and radiation injury.

Interleukin levels are higher in alopecia areata patients but don't predict disease severity or duration.

Activating Tgr5 may help treat hair loss and bone loss.

The research confirms that Hidradenitis Suppurativa is characterized by increased inflammation, disrupted skin cell organization, and abnormal metabolic processes.

Callicarpa nudiflora extract speeds up wound healing in scalded rats.

Soluble CD83 speeds up wound healing and reduces scarring.

Hair regrows faster in alopecia areata than skin re-pigments in vitiligo due to differences in stem cells and treatment effects.

Pimecrolimus reduces the effectiveness of stem cell therapy for atopic dermatitis.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Bone marrow-derived stem cells improved healing and reduced scarring in second-degree burns in rats.

Promising treatments for EBS include anti-inflammatory drugs, antibiotics, creams, mTOR inhibitors, and gene editing, but more trials are needed.

Udenafil may help hair grow by activating certain stem cells.

Targeting JAK-STAT1 can reduce inflammation and promote hair growth in conditions linked to EGFR deficiency.

Skin cells release substances important for healing and fighting infection, and understanding these could improve skin disorder treatments.